Share This Page
Drug Price Trends for ETONOGESTREL-EE VAGINAL RING
✉ Email this page to a colleague

Average Pharmacy Cost for ETONOGESTREL-EE VAGINAL RING
Drug Name | NDC | Price/Unit ($) | Unit | Date |
---|---|---|---|---|
ETONOGESTREL-EE VAGINAL RING | 16714-0029-01 | 53.61718 | EACH | 2025-06-18 |
ETONOGESTREL-EE VAGINAL RING | 00093-7679-02 | 53.61718 | EACH | 2025-06-18 |
ETONOGESTREL-EE VAGINAL RING | 66993-0605-81 | 53.61718 | EACH | 2025-06-18 |
>Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Market Analysis and Price Projections for Etonogestrel-Ethinyl Estradiol (EE) Vaginal Ring
Introduction
The etonogestrel-ethinyl estradiol (EE) vaginal ring, commonly known by brand names such as NuvaRing, is a popular contraceptive method that combines the benefits of both estrogen and progestin hormones. This analysis will delve into the market dynamics, pricing, and future projections for this contraceptive device.
Market Overview
The etonogestrel-EE vaginal ring is part of the broader contraceptive market, which is driven by increasing demand for effective and convenient birth control methods. This product has been well-received due to its ease of use, high efficacy, and minimal user intervention required once inserted[3].
Sales and Revenue
The etonogestrel-EE vaginal ring generates significant revenue. As of 2020, products containing etonogestrel and ethinyl estradiol had annual sales of over $837 million in the U.S. alone[4].
Pricing Dynamics
The cost of the etonogestrel-EE vaginal ring can vary based on several factors, including insurance coverage, pharmacy choice, and the presence of savings programs.
Retail Pricing
For cash-paying customers, the cost of a three-ring supply (a three-month cycle) can range from approximately $154 to $155, depending on the pharmacy and any available discounts[2][5].
Insurance and Savings Programs
The cost can be significantly reduced with insurance coverage or through savings programs. For instance, NuvaRing offers savings programs that can save users up to $475 per fill off the retail price[5].
Generic Versions
The introduction of generic versions, such as those by Teva Pharmaceuticals, has added a layer of competition and potentially lower costs. Generic versions like EluRyng contain the same active ingredients and are considered as safe and effective as the brand-name product, but often at a lower price point[4][5].
Market Competition
The market for contraceptive vaginal rings is relatively niche but competitive, with both brand-name and generic products available.
Brand-Name Products
NuvaRing is one of the most well-known brand-name products in this category. Its market presence and brand recognition contribute to its market share.
Generic Products
The launch of generic versions by companies like Teva has expanded the options for consumers, potentially reducing the market share of brand-name products. Generic versions are often preferred by insurance providers due to their lower cost without a compromise in efficacy[4].
Safety and Efficacy
The etonogestrel-EE vaginal ring has been shown to be highly effective and well-tolerated. Studies have demonstrated a Pearl Index of 0.65, indicating a low pregnancy rate among users. Additionally, cycle control is very good, with minimal irregular bleeding and high compliance rates[1].
Side Effects and Contraindications
While generally well-tolerated, the etonogestrel-EE vaginal ring has some common side effects such as spotting or light bleeding, breast discharge, and vaginal injury. It is contraindicated in women with certain medical conditions, including liver problems, high blood pressure, and a history of thrombotic events[3][4].
Future Projections
Market Growth
The demand for convenient and effective contraceptive methods is expected to continue growing, driven by increasing awareness and accessibility of birth control options. This trend is likely to sustain the market for etonogestrel-EE vaginal rings.
Pricing Trends
With the presence of generic versions, prices may stabilize or decrease slightly as competition increases. However, the brand-name products may maintain a premium due to their established market presence and consumer trust.
Regulatory and Technological Advancements
Any advancements in contraceptive technology or changes in regulatory environments could impact the market. For instance, improvements in material or design could enhance user comfort and compliance, potentially increasing market share.
Key Takeaways
- High Efficacy: The etonogestrel-EE vaginal ring is highly effective in preventing pregnancy, with a low Pearl Index.
- Market Competition: The market includes both brand-name and generic products, with generics offering a cost-effective alternative.
- Pricing: Costs vary based on insurance, pharmacy, and savings programs, with generic versions potentially offering lower prices.
- Safety and Tolerability: The product is generally well-tolerated but has specific contraindications and side effects.
- Future Growth: The market is expected to grow due to increasing demand for convenient birth control methods.
FAQs
Q: How effective is the etonogestrel-EE vaginal ring in preventing pregnancy?
A: The etonogestrel-EE vaginal ring is highly effective, with a Pearl Index of 0.65, indicating a low pregnancy rate among users[1].
Q: What are the common side effects of the etonogestrel-EE vaginal ring?
A: Common side effects include spotting or light bleeding, breast discharge, and vaginal injury. Less common side effects can include high blood sugar and high fat levels in the blood[4].
Q: Can I use the etonogestrel-EE vaginal ring if I have high blood pressure?
A: Women with well-controlled hypertension can use the etonogestrel-EE vaginal ring, but their blood pressure should be monitored closely. It is contraindicated in women with uncontrolled high blood pressure[3].
Q: How much does the etonogestrel-EE vaginal ring cost?
A: The cost can range from approximately $154 to $155 for a three-ring supply, depending on the pharmacy and any available discounts. Savings programs and insurance can significantly reduce the cost[2][5].
Q: Are generic versions of the etonogestrel-EE vaginal ring available?
A: Yes, generic versions such as EluRyng are available and contain the same active ingredients as the brand-name product. These generics are often preferred by insurance providers due to their lower cost[4][5].
Sources
- Human Reproduction: "Efficacy, tolerability and acceptability of a novel contraceptive vaginal ring releasing etonogestrel 120 μg and ethinyl oestradiol 15 μg daily over a period of 3 weeks"[1].
- Drugs.com: "Ethinyl estradiol/etonogestrel Prices, Coupons, Copay Cards & Patient Assistance"[2].
- Drugs.com: "Etonogestrel and Ethinyl Estradiol Vaginal Insert - Drugs.com"[3].
- Teva Pharmaceuticals: "Teva Announces Launch of a Generic Version of NuvaRing® (etonogestrel and ethinyl estradiol) Vaginal Ring in the United States"[4].
- Medical News Today: "NuvaRing cost 2024: Coupons and more"[5].
More… ↓